MSO Ascend Wellness Holdings claimed MSO MedMen had challenged the authority of New York regulators. The accusation comes after MedMen announced, earlier this week, that it would terminate a deal to be sell more than 86% of its New York business to Ascend for $73M.
- Ascend alleges MedMen is backing out of the deal on grounds that it was not cleared by New York state regulators. Ascend says state regulators approved the deal.
- In a letter filed with the Securities and Exchange Commission, Ascend CFO Dan Neville calls MedMen’s position “absurd.” (As far as I’m aware, MedMen hasn’t publicly stated this position.)
- New York patients and communities “should not be pawns in your corporate machinations.”
- MedMen has not made any public statements since Monday when it said it was ending the deal but did not give a reason.
- Since the investment announcement in February, New York legalized REC and created a highly anticipated market.
Separately, Ascend announced the close of a previously announced deal to buy two Chicago pot shops.
Share:
Already a Pro member? Login here
pro
Fresno’s bitterly-fought licensing process
In May 2021, social equity applicant George Boyadjian wrote to Fresno’s (Kern Co.) mayor and city council. He had a problem with a former LA Dodger and a former NBA player applying for social equity licenses in the city. “When...
pro
Canopy deal secured, Jetty Extracts makes plans
Canadian operator Canopy Growth has paid $69M for the right to acquire California concentrate brand Jetty Extracts, once federal law permits.In the time until Canopy can close the acquisition, Jetty CEO and co-founder Ron Gershoni said he plans to prepare...
pro
Calif. distru. wars: Herbl vs. Nabis and Raw Garden lawsuit gets nasty
California’s two leading distributors Herbl and Nabis and one of its top concentrate makers, Raw Garden, are locked in a nasty legal battle over Raw Garden’s switch from Herbl to Nabis early this year.On January 7, John de Friel, CEO...
